Garrett M Nash
Overview
Explore the profile of Garrett M Nash including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
145
Citations
3703
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mahmoud A, Choi P, Sukhwa C, Pintar J, Walch H, Zhao N, et al.
bioRxiv
. 2025 Mar;
PMID: 40027618
Peritoneal carcinomatosis is a common yet deadly manifestation of gastrointestinal cancers, with few effective treatments. To identify targetable determinants of peritoneal metastasis, we focused on appendiceal adenocarcinoma (AC), a gastrointestinal...
2.
Rosen R, Rosen R, Bercz A, Bercz A, Omer D, Omer D, et al.
Dis Colon Rectum
. 2025 Jan;
68(3):300-307.
PMID: 39808079
Background: The watch-and-wait strategy provides an opportunity to pursue nonoperative management in rectal cancer patients with clinical complete response after neoadjuvant therapy. The management of those with near-complete response remains...
3.
Schleimer L, Hakki L, Seier K, Seo S, Cohen N, Usiak S, et al.
Ann Surg Oncol
. 2024 Dec;
32(4):2505-2506.
PMID: 39692984
No abstract available.
4.
Aguirre N, Chung S, Foote M, Shia J, Vakiani E, Gowda T, et al.
Ann Surg Oncol
. 2024 Nov;
32(2):695-702.
PMID: 39604747
Background: Appendiceal epithelial tumors are rare and encompass a broad set of adenocarcinoma histologies, including mucinous (mAC), colonic-type (cAC), and goblet cell (GCA) adenocarcinomas. It has previously been reported that...
5.
Aguirre N, Chung S, Foote M, Shia J, Vakiani E, Gowda T, et al.
Ann Surg Oncol
. 2024 Nov;
32(2):715-716.
PMID: 39576452
No abstract available.
6.
Schleimer L, Hakki L, Seier K, Seo S, Cohen N, Usiak S, et al.
Ann Surg Oncol
. 2024 Nov;
32(2):1043-1053.
PMID: 39570297
Background: Surgical site infections (SSIs) are a major driver of morbidity after combined liver and colorectal surgery for metastatic colorectal cancer. Available literature is inadequate to characterize risk factors and...
7.
Rosen R, Bartsch C, Thompson E, Letika-Kreigel A, Kaur Y, Ng S, et al.
J Surg Oncol
. 2024 Nov;
PMID: 39523936
Background And Objectives: Infrequent preoperative goals of care (GOC) documentation leads to challenges in medical decision-making when patients experience postoperative complications. We evaluated the feasibility of enhancing GOC documentation through...
8.
Feferman Y, Verheij F, Williams H, Omer D, Pappou E, Wei I, et al.
Ann Surg Oncol
. 2024 Nov;
32(1):184-185.
PMID: 39496902
No abstract available.
9.
Feferman Y, Verheij F, Williams H, Omer D, Pappou E, Wei I, et al.
Ann Surg Oncol
. 2024 Oct;
32(1):128-136.
PMID: 39395915
Introduction: Total mesorectal excision (TME) with intersphincteric resection and handsewn coloanal anastomosis (ISR-CAA) has been shown to be oncologically safe in patients with distal rectal cancer treated with preoperative chemoradiation....
10.
Offin M, Aguirre N, Yang S, Sauter J, Karagkounis G, Mohamed M, et al.
Ann Surg Oncol
. 2024 Aug;
31(12):7973-7977.
PMID: 39167353
Purpose: Well-differentiated papillary peritoneal mesothelial tumors (WDPMTs) are understudied and discrete from peritoneal mesotheliomas (PMs). We report clinicopathologic characteristics and outcomes of a large prospective WDPMT cohort. Methods: Patients with...